November 19, 2023
1 min watch
Save
VIDEO: J&J Vision chief medical officer discusses developments in IOLs
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Rajesh K. Rajpal, MD, chief medical officer at Johnson & Johnson Vision, discusses the company’s latest developments.
Johnson & Johnson’s latest technological developments include Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management, the Tecnis Synergy IOL and Symfony OptiBlue IOL.
“It’s been an exciting year, [we’ve seen] exciting progress in many of our technologies, and we love the partnership with ophthalmologists,” Rajpal said.
Editor's note: The headline of this article was updated on Monday, Nov. 20, to correct the name of the company.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Rajpal reports being chief medical officer at Johnson & Johnson Vision.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.